Streptococcus agalactiae 2603 V/R is a facultative anaerobe, Gram-positive, coccus-shaped bacterium that was isolated from Human, Clinical specimen.
Gram-positive coccus-shaped facultative anaerobe Bacteria| @ref 20215 |
Last LPSN update
2026-02-09 11:32:46 |
| Domain Bacteria |
| Phylum Bacillota |
| Class Bacilli |
| Order Lactobacillales |
| Family Streptococcaceae |
| Genus Streptococcus |
| Species Streptococcus agalactiae |
| Full scientific name Streptococcus agalactiae Lehmann and Neumann 1896 (Approved Lists 1980) |
| Synonyms (2) |
| 36670 | Oxygen tolerancefacultative anaerobe |
| @ref | Salt | Growth | Tested relation | Concentration | |
|---|---|---|---|---|---|
| 36670 | NaCl | growth | 6.5 % |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68371 | 27613 ChEBI | amygdalin | - | builds acid from | from API 50CH acid |
| 68371 | 17057 ChEBI | cellobiose | - | builds acid from | from API 50CH acid |
| 68371 | 17108 ChEBI | D-arabinose | - | builds acid from | from API 50CH acid |
| 68371 | 18333 ChEBI | D-arabitol | - | builds acid from | from API 50CH acid |
| 68371 | 15824 ChEBI | D-fructose | + | builds acid from | from API 50CH acid |
| 68371 | 28847 ChEBI | D-fucose | - | builds acid from | from API 50CH acid |
| 68371 | 12936 ChEBI | D-galactose | + | builds acid from | from API 50CH acid |
| 68371 | 17634 ChEBI | D-glucose | + | builds acid from | from API 50CH acid |
| 68371 | 62318 ChEBI | D-lyxose | - | builds acid from | from API 50CH acid |
| 68371 | 16899 ChEBI | D-mannitol | - | builds acid from | from API 50CH acid |
| 68371 | 16024 ChEBI | D-mannose | + | builds acid from | from API 50CH acid |
| 68371 | 16988 ChEBI | D-ribose | + | builds acid from | from API 50CH acid |
| 68371 | 17924 ChEBI | D-sorbitol | - | builds acid from | from API 50CH acid |
| 68371 | 16443 ChEBI | D-tagatose | - | builds acid from | from API 50CH acid |
| 68371 | 65327 ChEBI | D-xylose | - | builds acid from | from API 50CH acid |
| 68371 | 17113 ChEBI | erythritol | - | builds acid from | from API 50CH acid |
| 36670 | 4853 ChEBI | esculin | - | hydrolysis | |
| 68371 | 4853 ChEBI | esculin | - | builds acid from | from API 50CH acid |
| 68371 | 16813 ChEBI | galactitol | - | builds acid from | from API 50CH acid |
| 68371 | 28066 ChEBI | gentiobiose | - | builds acid from | from API 50CH acid |
| 68371 | 24265 ChEBI | gluconate | - | builds acid from | from API 50CH acid |
| 68371 | 17754 ChEBI | glycerol | - | builds acid from | from API 50CH acid |
| 68371 | 28087 ChEBI | glycogen | - | builds acid from | from API 50CH acid |
| 36670 | 606565 ChEBI | hippurate | + | hydrolysis | |
| 68371 | 15443 ChEBI | inulin | - | builds acid from | from API 50CH acid |
| 68371 | 30849 ChEBI | L-arabinose | - | builds acid from | from API 50CH acid |
| 68371 | 18403 ChEBI | L-arabitol | - | builds acid from | from API 50CH acid |
| 68371 | 18287 ChEBI | L-fucose | - | builds acid from | from API 50CH acid |
| 68371 | 62345 ChEBI | L-rhamnose | - | builds acid from | from API 50CH acid |
| 68371 | 17266 ChEBI | L-sorbose | - | builds acid from | from API 50CH acid |
| 68371 | 65328 ChEBI | L-xylose | - | builds acid from | from API 50CH acid |
| 68371 | 17716 ChEBI | lactose | - | builds acid from | from API 50CH acid |
| 68371 | 17306 ChEBI | maltose | + | builds acid from | from API 50CH acid |
| 68371 | 6731 ChEBI | melezitose | - | builds acid from | from API 50CH acid |
| 68371 | 28053 ChEBI | melibiose | - | builds acid from | from API 50CH acid |
| 68371 | 320061 ChEBI | methyl alpha-D-glucopyranoside | - | builds acid from | from API 50CH acid |
| 68371 | 43943 ChEBI | methyl alpha-D-mannoside | - | builds acid from | from API 50CH acid |
| 68371 | 74863 ChEBI | methyl beta-D-xylopyranoside | - | builds acid from | from API 50CH acid |
| 68371 | 17268 ChEBI | myo-inositol | - | builds acid from | from API 50CH acid |
| 68371 | 59640 ChEBI | N-acetylglucosamine | + | builds acid from | from API 50CH acid |
| 36670 | 17632 ChEBI | nitrate | - | reduction | |
| 36670 | 16301 ChEBI | nitrite | - | reduction | |
| 68371 | Potassium 2-ketogluconate | - | builds acid from | from API 50CH acid | |
| 68371 | 16634 ChEBI | raffinose | - | builds acid from | from API 50CH acid |
| 68371 | 15963 ChEBI | ribitol | - | builds acid from | from API 50CH acid |
| 68371 | 17814 ChEBI | salicin | + | builds acid from | from API 50CH acid |
| 68371 | 17992 ChEBI | sucrose | + | builds acid from | from API 50CH acid |
| 68371 | 27082 ChEBI | trehalose | + | builds acid from | from API 50CH acid |
| 68371 | 32528 ChEBI | turanose | - | builds acid from | from API 50CH acid |
| 68371 | 17151 ChEBI | xylitol | - | builds acid from | from API 50CH acid |
| @ref | Metabolite | Is sensitive | Is resistant | |
|---|---|---|---|---|
| 36670 | 0129 (2,4-Diamino-6,7-di-iso-propylpteridine phosphate) |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 36670 | alcohol dehydrogenase | + | 1.1.1.1 | |
| 68382 | alkaline phosphatase | + | 3.1.3.1 | from API zym |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | + | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 36670 | beta-galactosidase | - | 3.2.1.23 | |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68382 | beta-glucuronidase | + | 3.2.1.31 | from API zym |
| 36670 | catalase | - | 1.11.1.6 | |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 68382 | esterase (C 4) | - | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 36670 | gamma-glutamyltransferase | - | 2.3.2.2 | |
| 68382 | leucine arylamidase | + | 3.4.11.1 | from API zym |
| 68382 | lipase (C 14) | - | from API zym | |
| 36670 | lysine decarboxylase | - | 4.1.1.18 | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 36670 | ornithine decarboxylase | - | 4.1.1.17 | |
| 36670 | oxidase | - | ||
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 68382 | valine arylamidase | - | from API zym |
| @ref | ControlQ | GLY | ERY | DARA | LARA | RIB | DXYL | LXYL | ADO | MDX | GAL | GLU | FRU | MNE | SBE | RHA | DUL | INO | MAN | SOR | MDM | MDG | NAG | AMY | ARB | ESC | SAL | CEL | MAL | LAC | MEL | SAC | TRE | INU | MLZ | RAF | AMD | GLYG | XLT | GEN | TUR | LYX | TAG | DFUC | LFUC | DARL | LARL | GNT | 2KG | 5KG | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36670 | not determinedn.d. | - | - | - | - | + | - | - | - | - | + | + | + | + | - | - | - | - | - | - | - | - | + | - | +/- | - | + | - | + | - | - | + | + | - | - | - | +/- | - | - | - | - | - | - | - | - | - | - | - | - | +/- |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Genetics | Harnessing subtractive genomics for drug target identification in Streptococcus agalactiae serotype v (atcc baa-611 / 2603 v/r) strain: An in-silico approach. | Chowdhury ARK, Tithi FY, Bhuiyan NZ, Ishita AF, Sohel MMH. | PLoS One | 10.1371/journal.pone.0319368 | 2025 | |
| Selected Polyphenols of Polish Poplar Propolis as a Key Component Shaping Its Antibacterial Properties-In Vitro and In Silico Approaches. | Dzugan M, Milek M, Ciszkowicz E, Lyskowski A, Tomczyk M. | Molecules | 10.3390/molecules30092036 | 2025 | | |
| Phylogeny | The variation of gut microbiota in captive Sichuan golden snub-nosed monkeys (Rhinopithecus roxellana) from infancy to adulthood. | Chen R, Liu X, Wang S, Guo L, Li M, Xu X, Lv R, Hong L, Wang G, Deng C, Sun W, Liu G. | Front Vet Sci | 10.3389/fvets.2025.1683047 | 2025 | |
| Development and evaluation of a multi-epitope subunit vaccine against group B Streptococcus infection. | Zhang Y, Liang S, Zhang S, Zhang S, Yu Y, Yao H, Liu Y, Zhang W, Liu G. | Emerg Microbes Infect | 10.1080/22221751.2022.2122585 | 2022 | | |
| Using Surface Immunogenic Protein as a Carrier Protein to Elicit Protective Antibody to Multiple Serotypes for Candidate Group B Streptococcal Glycan Conjugate Vaccines. | Duan H, Huang W, Lv Q, Liu P, Li Q, Kong D, Sun X, Zhang X, Jiang Y, Chen S. | Vaccines (Basel) | 10.3390/vaccines12060573 | 2024 | | |
| Genetics | Bacteriocin Producing Streptococcus agalactiae Strains Isolated from Bovine Mastitis in Brazil. | Vidal Amaral JR, Juca Ramos RT, Almeida Araujo F, Bentes Kato R, Figueira Aburjaile F, de Castro Soares S, Goes-Neto A, Matiuzzi da Costa M, Azevedo V, Brenig B, Soares de Oliveira S, Soares Rosado A. | Microorganisms | 10.3390/microorganisms10030588 | 2022 | |
| Pathogenicity | Vaginal host immune-microbiome-metabolite interactions associated with spontaneous preterm birth in a predominantly white cohort. | Cavanagh M, Amabebe E, Kulkarni NS, Papageorgiou MD, Walker H, Wyles MD, Anumba DO. | NPJ Biofilms Microbiomes | 10.1038/s41522-025-00671-4 | 2025 | |
| Pathogenicity | Analysis of multidrug resistant group B streptococci with reduced penicillin susceptibility forming small, less hemolytic colonies. | Banno H, Kimura K, Tanaka Y, Sekizuka T, Kuroda M, Jin W, Wachino JI, Yamada K, Shibayama K, Arakawa Y. | PLoS One | 10.1371/journal.pone.0183453 | 2017 | |
| Enzymology | Isolation of group B Streptococcus with reduced beta-lactam susceptibility from pregnant women. | Moroi H, Kimura K, Kotani T, Tsuda H, Banno H, Jin W, Wachino JI, Yamada K, Mitsui T, Yamashita M, Kikkawa F, Arakawa Y. | Emerg Microbes Infect | 10.1080/22221751.2018.1557987 | 2019 | |
| Metabolism | Flavodoxins as Novel Therapeutic Targets against Helicobacter pylori and Other Gastric Pathogens. | Salillas S, Sancho J. | Int J Mol Sci | 10.3390/ijms21051881 | 2020 | |
| Axiom Microbiome Array, the next generation microarray for high-throughput pathogen and microbiome analysis. | Thissen JB, Be NA, McLoughlin K, Gardner S, Rack PG, Shapero MH, Rowland RRR, Slezak T, Jaing CJ. | PLoS One | 10.1371/journal.pone.0212045 | 2019 | | |
| Capsular Type, Sequence Type and Microbial Resistance Factors Impact on DNase Activity of Streptococcus agalactiae Strains from Human and Bovine Origin. | Florindo C, Barroco CA, Silvestre I, Damiao V, Gomes JP, Spellerberg B, Santos-Sanches I, Borrego MJ. | Eur J Microbiol Immunol (Bp) | 10.1556/1886.2018.00026 | 2018 | | |
| Phylogeny | Offline Next Generation Metagenomics Sequence Analysis Using MinION Detection Software (MINDS). | Deshpande SV, Reed TM, Sullivan RF, Kerkhof LJ, Beigel KM, Wade MM. | Genes (Basel) | 10.3390/genes10080578 | 2019 | |
| Glutathione Synthesis Contributes to Virulence of Streptococcus agalactiae in a Murine Model of Sepsis. | Walker EA, Port GC, Caparon MG, Janowiak BE. | J Bacteriol | 10.1128/jb.00367-19 | 2019 | | |
| Pathogenicity | Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy. | Piccinelli G, Gargiulo F, Corbellini S, Ravizzola G, Bonfanti C, Caruso A, De Francesco MA. | Antimicrob Agents Chemother | 10.1128/aac.05127-14 | 2015 | |
| A common protocol for the simultaneous processing of multiple clinically relevant bacterial species for whole genome sequencing. | Raven KE, Girgis ST, Akram A, Blane B, Leek D, Brown N, Peacock SJ. | Sci Rep | 10.1038/s41598-020-80031-8 | 2021 | | |
| Seroprevalence of Opsonophagocytic Antibodies against Serotype Ia, Ib, II, III, and V Group B Streptococcus among Korean Population. | Lee JH, Kim HW, Kim KH. | J Korean Med Sci | 10.3346/jkms.2018.33.e127 | 2018 | | |
| The Chitosan-Based System with Scutellariae baicalensis radix Extract for the Local Treatment of Vaginal Infections. | Chanaj-Kaczmarek J, Rosiak N, Szymanowska D, Rajewski M, Wender-Ozegowska E, Cielecka-Piontek J. | Pharmaceutics | 10.3390/pharmaceutics14040740 | 2022 | | |
| Enzymology | Molecular epidemiology of Streptococcus agalactiae isolated from mastitis in Brazilian dairy herds. | Carvalho-Castro GA, Silva JR, Paiva LV, Custodio DAC, Moreira RO, Mian GF, Prado IA, Chalfun-Junior A, Costa GM. | Braz J Microbiol | 10.1016/j.bjm.2017.02.004 | 2017 | |
| Immunochromatographic detection of the group B streptococcus antigen from enrichment cultures. | Matsui H, Kimura J, Higashide M, Takeuchi Y, Okue K, Cui L, Nakae T, Sunakawa K, Hanaki H. | Clin Vaccine Immunol | 10.1128/cvi.00171-13 | 2013 | | |
| Pathogenicity | In Vitro Activity of Quaternary Ammonium Surfactants against Streptococcal, Chlamydial, and Gonococcal Infective Agents. | Inacio AS, Nunes A, Milho C, Milho C, Mota LJ, Borrego MJ, Gomes JP, Vaz WL, Vieira OV. | Antimicrob Agents Chemother | 10.1128/aac.00166-16 | 2016 | |
| Pathogenicity | First molecular characterization of group B streptococci with reduced penicillin susceptibility. | Kimura K, Suzuki S, Wachino J, Kurokawa H, Yamane K, Shibata N, Nagano N, Kato H, Shibayama K, Arakawa Y. | Antimicrob Agents Chemother | 10.1128/aac.00185-08 | 2008 | |
| Phylogeny | NG-Tax 2.0: A Semantic Framework for High-Throughput Amplicon Analysis. | Poncheewin W, Hermes GDA, van Dam JCJ, Koehorst JJ, Smidt H, Schaap PJ. | Front Genet | 10.3389/fgene.2019.01366 | 2019 | |
| Enzymology | Antimicrobial susceptibility profiles, serotype distribution and virulence determinants among invasive, non-invasive and colonizing Streptococcus agalactiae (group B streptococcus) from Malaysian patients. | Eskandarian N, Ismail Z, Neela V, van Belkum A, Desa MN, Amin Nordin S. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-014-2265-x | 2015 | |
| Pathogenicity | Penicillin-susceptible group B streptococcal clinical isolates with reduced cephalosporin susceptibility. | Nagano N, Nagano Y, Toyama M, Kimura K, Shibayama K, Arakawa Y. | J Clin Microbiol | 10.1128/jcm.01291-14 | 2014 | |
| Synthesis and Biological Evaluation of Novel Cinnamic Acid-Based Antimicrobials. | Mingoia M, Conte C, Di Rienzo A, Dimmito MP, Marinucci L, Magi G, Turkez H, Cufaro MC, Del Boccio P, Di Stefano A, Cacciatore I. | Pharmaceuticals (Basel) | 10.3390/ph15020228 | 2022 | | |
| Enzymology | Molecular characterization of Streptococcus agalactiae isolated from bovine mastitis in Eastern China. | Yang Y, Liu Y, Ding Y, Yi L, Ma Z, Fan H, Lu C. | PLoS One | 10.1371/journal.pone.0067755 | 2013 | |
| Streptococcus salivarius K12 Limits Group B Streptococcus Vaginal Colonization. | Patras KA, Wescombe PA, Rosler B, Hale JD, Tagg JR, Doran KS. | Infect Immun | 10.1128/iai.00409-15 | 2015 | | |
| Pathogenicity | Practical disk diffusion test for detecting group B streptococcus with reduced penicillin susceptibility. | Kimura K, Wachino J, Kurokawa H, Suzuki S, Yamane K, Shibata N, Arakawa Y. | J Clin Microbiol | 10.1128/jcm.02063-08 | 2009 | |
| Phylogeny | Integrated Counts of Carbohydrate-Active Protein Domains as Metabolic Readouts to Distinguish Probiotic Biology and Human Fecal Metagenomes. | Liu HH, Lin YC, Chung CS, Liu K, Chang YH, Yang CH, Chen Y, Ni YH, Chang PF. | Sci Rep | 10.1038/s41598-019-53173-7 | 2019 | |
| Phylogeny | Sequencing 16S rRNA gene fragments using the PacBio SMRT DNA sequencing system. | Schloss PD, Jenior ML, Koumpouras CC, Westcott SL, Highlander SK. | PeerJ | 10.7717/peerj.1869 | 2016 | |
| mockrobiota: a Public Resource for Microbiome Bioinformatics Benchmarking. | Bokulich NA, Rideout JR, Mercurio WG, Shiffer A, Wolfe B, Maurice CF, Dutton RJ, Turnbaugh PJ, Knight R, Caporaso JG. | mSystems | 10.1128/msystems.00062-16 | 2016 | | |
| Pathogenicity | Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility. | Nagano N, Nagano Y, Kimura K, Tamai K, Yanagisawa H, Arakawa Y. | Antimicrob Agents Chemother | 10.1128/aac.00596-08 | 2008 | |
| Genetics | Do you cov me? Effect of coverage reduction on metagenome shotgun sequencing studies. | Cattonaro F, Spadotto A, Radovic S, Marroni F. | F1000Res | 10.12688/f1000research.16804.4 | 2018 | |
| Genetics | Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. | Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. | Appl Environ Microbiol | 10.1128/aem.01043-13 | 2013 | |
| Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. | Cheng Q, Nelson D, Zhu S, Fischetti VA. | Antimicrob Agents Chemother | 10.1128/aac.49.1.111-117.2005 | 2005 | | |
| Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. | Haas BJ, Gevers D, Earl AM, Feldgarden M, Ward DV, Giannoukos G, Ciulla D, Tabbaa D, Highlander SK, Sodergren E, Methe B, DeSantis TZ, Human Microbiome Consortium, Petrosino JF, Knight R, Birren BW. | Genome Res | 10.1101/gr.112730.110 | 2011 | | |
| Genetics | Evaluation of 16S rDNA-based community profiling for human microbiome research. | Jumpstart Consortium Human Microbiome Project Data Generation Working Group. | PLoS One | 10.1371/journal.pone.0039315 | 2012 | |
| Pathogenicity | Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands. | Schmelcher M, Powell AM, Becker SC, Camp MJ, Donovan DM. | Appl Environ Microbiol | 10.1128/aem.07050-11 | 2012 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive136919.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License